Wells Fargo & Company Dynavax Technologies Corp Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Wells Fargo & Company holds 50,576 shares of DVAX stock, worth $628,153. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,576
Previous 92,954 45.59%
Holding current value
$628,153
Previous $1.04 Million 46.02%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$10.05 - $11.61 $425,898 - $492,008
-42,378 Reduced 45.59%
50,576 $563,000
Q2 2024

Aug 13, 2024
BUY
$10.73 - $12.58 $536,660 - $629,188
50,015 Added 116.48%
92,954 $1.04 Million
Q1 2024

May 10, 2024
BUY
$11.7 - $14.98 $44,085 - $56,444
3,768 Added 9.62%
42,939 $532,000
Q4 2023

Feb 09, 2024
SELL
$13.09 - $14.98 $1.04 Million - $1.19 Million
-79,117 Reduced 66.89%
39,171 $547,000
Q3 2023

Nov 13, 2023
SELL
$12.64 - $14.99 $252,092 - $298,960
-19,944 Reduced 14.43%
118,288 $1.75 Million
Q2 2023

Aug 15, 2023
BUY
$9.85 - $13.17 $149,897 - $200,421
15,218 Added 12.37%
138,232 $1.79 Million
Q1 2023

May 12, 2023
BUY
$9.44 - $11.88 $1.04 Million - $1.3 Million
109,725 Added 825.68%
123,014 $1.21 Million
Q4 2022

Feb 13, 2023
SELL
$10.27 - $13.29 $64,988 - $84,099
-6,328 Reduced 32.26%
13,289 $141,000
Q3 2022

Nov 14, 2022
SELL
$9.93 - $17.44 $8,559 - $15,033
-862 Reduced 4.21%
19,617 $205,000
Q2 2022

Aug 12, 2022
SELL
$7.45 - $12.83 $805,583 - $1.39 Million
-108,132 Reduced 84.08%
20,479 $258,000
Q1 2022

May 16, 2022
SELL
$9.75 - $14.44 $297,765 - $440,997
-30,540 Reduced 19.19%
128,611 $1.39 Million
Q4 2021

Feb 14, 2022
SELL
$13.17 - $20.94 $4.39 Million - $6.98 Million
-333,489 Reduced 67.69%
159,151 $2.24 Million
Q3 2021

Nov 15, 2021
BUY
$9.16 - $19.83 $2.97 Million - $6.42 Million
323,825 Added 191.82%
492,640 $9.46 Million
Q2 2021

Aug 16, 2021
BUY
$7.25 - $10.99 $774,822 - $1.17 Million
106,872 Added 172.53%
168,815 $1.66 Million
Q1 2021

May 13, 2021
SELL
$4.57 - $11.18 $668,600 - $1.64 Million
-146,302 Reduced 70.25%
61,943 $609,000
Q4 2020

Feb 09, 2021
BUY
$3.73 - $5.6 $10,850 - $16,290
2,909 Added 1.42%
208,245 $926,000
Q3 2020

Nov 05, 2020
BUY
$4.32 - $11.7 $40,284 - $109,102
9,325 Added 4.76%
205,336 $887,000
Q2 2020

Aug 13, 2020
BUY
$2.94 - $9.1 $431,053 - $1.33 Million
146,617 Added 296.83%
196,011 $1.74 Million
Q1 2020

May 14, 2020
BUY
$2.27 - $6.2 $112,124 - $306,242
49,394 New
49,394 $175,000

Others Institutions Holding DVAX

# of Institutions
274
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.57B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email